In HNSCC, TMEM16A overexpression has been associated with proliferation and tumor growth [15, 29], worse prognosis [15, 30] and undermining of clinical outcomes following platinum-based chemotherapy [31]. The gene discussed is ANO1; the disease is neoplasm.